What is Climb Bio, Inc.'s financing cash flow?

Climb Bio, Inc. (CLYM) reported financing cash flow of $5K in Q1 2026.

What is the long-term trend for Climb Bio, Inc.'s financing cash flow?

Over 4 years (2021 to 2025), Climb Bio, Inc.'s financing cash flow has grown at a -89.6% compound annual growth rate (CAGR), from $177.23M to -$21K.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Climb Bio, Inc. CLYM Financing Cash Flow

Financing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$1.56B-57.1%

AmgenAMGN

$1.44B+135%

Vera TherapeuticsVERA

$3.94M+157%

Kyverna Therapeutics, Inc.KYTX

-$101K+75.6%

Cullinan Therapeutics, Inc.CGEM

$380K—

Jade Biosciences, Inc. Common StockJBIO

-$795K-13.6%

Other financials

Income statement

See full

Operating income-$15.2M+33.9%

Net income-$13.7M+34.0%

EPS (diluted)-$0.20+35.5%

Balance sheet

See full

Cash & equivalents$8.4M-71.2%

Total debt$479.0K+1.1%

Total equity$148.1M-23.4%

Total assets$152.4M-24.1%

Cash flow

See full

Operating cash flow-$14.4M+6.8%

CapEx$109.0K—

Free cash flow-$15.6M-183%

Valuation

See full

Market cap$724.95M+787%

Enterprise value$717.07M+1,247%

Returns & leverage

See full

Return on equity-30.9%-10.3pp

Debt / equity0×0.0×

Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Climb Bio, Inc.'s financing cash flow?: Climb Bio, Inc. (CLYM) reported financing cash flow of $5K in Q1 2026.
What is the long-term trend for Climb Bio, Inc.'s financing cash flow?: Over 4 years (2021 to 2025), Climb Bio, Inc.'s financing cash flow has grown at a -89.6% compound annual growth rate (CAGR), from $177.23M to -$21K.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.